Live Breaking News & Updates on International Private Placement|Page 3

Stay updated with breaking news from International private placement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Carbios Successfully Completes Its Capital Increase and Raises €114 Million, Setting a Key Milestone for Its Industrial Development Plans


Carbios Successfully Completes Its Capital Increase and Raises €114 Million, Setting a Key Milestone for Its Industrial Development Plans
o/w other
Stake in the capital increase
(in euros)
Business Opportunities for L Oréal Development (BOLD)
482,834
486,400
To the Company s knowledge, the distribution of the Company s shareholding (on a non-diluted basis) on the date of the AMF s approval on the Prospectus (as defined below) and following the completion of the capital increase was and will be as follows:
Before the Offering
of voting rights
46,511
482,834
100.0%
(1) Excludes the shares of Truffle Capital funds which have a dedicated separate line in the table
(2) Shares held by funds and or individuals whose management company is Copernicus Wealth Management ....

United States , France General , United Kingdom , Jean Yves Barbara , Marie Virginie Klein , Benjamin Audebert , Carbios Linkedin , Jean Claude Lumaret , Katel Barrette , Carbios Instagram , Loccitane Group , Group Loccitane , European Parliament , Garnier Co , Financial Services , International Private Placement , European Union , European Union Withdrawal , Global Offering , Michelin Ventures , Copernicus Wealth , Loccitane Group , Euronext Growth Paris , Garnier Co Limited , Bryan Garnier Securities , Securities Act ,

CARMAT Announces the Results of Its Capital Increase of €55.7 Million After Exercise of the Increase Option


Provided by
Business Wire
Mar 8, 2021 9:59 PM UTC
CARMAT Announces the Results of Its Capital Increase of €55.7 Million After Exercise of the Increase Option
Not for Distribution in the United States of America, Canada, Australia or Japan
Regulatory News:
CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart 1, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure (the “ Company”), today announces the results of its capital increase launched on February 26, 2021 which implemented without shareholders’ preferential subscription rights by way of a public offering and with a priority subscription period, on an irreducible basis ( à titre irréductible) only, to its existing shareholders and a global offering (the “ Offering”), for an amount (including the issue ....

United States , France General , United Kingdom , Pierre Bastid , Alain Carpentier , Ligresti Sant , Pierre Bastid Lohas , Kepler Cheuvreux , Dusan Oresansky , Caroline Carmagnol , French Health Authority , European Council , Airbus Group , Centre Chirurgical Marie Lannelongue , International Private Placement , European Union , European Union Withdrawal , Hc Wainwright Co , European Investment Bank , European Parliament , Drug Administration , European Commission , Financial Services , Ladenburg Thalmann Co , Health Care , Its Capital Increase ,